Back to Search
Start Over
beta-lactamases in bacteroides.
- Source :
-
Scandinavian journal of infectious diseases. Supplementum [Scand J Infect Dis Suppl] 1978 (13), pp. 27-32. - Publication Year :
- 1978
-
Abstract
- Bacteroides fragilis is responsible for most anaerobic infections in man. Most isolates of B. fragilis show resistance to beta-lactam antibiotics. This resistance might be due to beta-lactamase production or permeability barrier in the cell wall. B. fragilis produce beta-lactamase with mainly cephalosporinase activity. Other Bacteroides species such as B. clostridiformis, B. melaninogenicus and B. oralis also produce beta-lactamase but with different biochemical characteristics.
- Subjects :
- Anti-Bacterial Agents therapeutic use
Bacteriological Techniques
Bacteroides fragilis enzymology
Cefamandole therapeutic use
Cefoxitin therapeutic use
Cell Wall enzymology
Furans therapeutic use
Humans
Isoelectric Focusing
Penicillin G therapeutic use
Penicillin Resistance
Penicillins therapeutic use
Prevotella melaninogenica enzymology
Species Specificity
beta-Lactams therapeutic use
Amidohydrolases metabolism
Bacteroides enzymology
Bacteroides Infections drug therapy
Cephalosporinase metabolism
Cephalosporins therapeutic use
Penicillinase metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 0300-8878
- Issue :
- 13
- Database :
- MEDLINE
- Journal :
- Scandinavian journal of infectious diseases. Supplementum
- Publication Type :
- Academic Journal
- Accession number :
- 28561